220 related articles for article (PubMed ID: 33392216)
1. Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen.
Quattrocchio G; Barreca A; Vaccarino A; Del Vecchio G; De Simone E; Fenoglio R; Ferro M; Pagliaro M; Pini M; Manes M; Roccatello D
Front Med (Lausanne); 2020; 7():587345. PubMed ID: 33392216
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
Huang J; Sun C; Su H; Zhang C; Xiong J
Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
[TBL] [Abstract][Full Text] [Related]
5. Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS).
Vankalakunti M; Bonu R; Shetty S; Siddini V; Babu K; Ballal SH
Clin Kidney J; 2014 Jun; 7(3):296-8. PubMed ID: 25852893
[TBL] [Abstract][Full Text] [Related]
6. PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
Rahbari E; Barreca A; Nicolino B; Ciochetto C; Piraina V; Maroni S; Deagostini MC; Patti R; Bertucci P; Savoldi S
G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191627
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].
Manes M; Radin E; Pellu' V; Molino A A; Gabrielli D; Parodi E; Caputo D; Paternoster G; Barreca A; Pagliaro M; Quattrocchio G; Roccatello D
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373468
[TBL] [Abstract][Full Text] [Related]
8. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F; Javaugue V; Nasr SH; Leung N
Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
[TBL] [Abstract][Full Text] [Related]
9. Proliferative Glomerulonephritis With Monoclonal IgG3λ Deposits: A Case Report of a Rare Cause of Monoclonal Gammopathy of Renal Significance.
Yu XJ; Wang MJ; Yong ZH; Ma YY; Wang SX; Zhou FD; Zhao MH
Kidney Med; 2019; 1(4):221-225. PubMed ID: 32734203
[TBL] [Abstract][Full Text] [Related]
10. Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.
Javaugue V; Dufour-Nourigat L; Desport E; Sibille A; Moulin B; Bataille P; Bindi P; Garrouste C; Mariat C; Karlin L; Nouvier M; Goujon JM; Gnemmi V; Fermand JP; Touchard G; Bridoux F
Kidney Int; 2021 Feb; 99(2):421-430. PubMed ID: 32739419
[TBL] [Abstract][Full Text] [Related]
11. Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report.
Rana R; Cockwell P; Vydianath B; Cook M; Pratt G; Drayson MT; Pinney JH
Mayo Clin Proc Innov Qual Outcomes; 2018 Sep; 2(3):297-302. PubMed ID: 30225464
[TBL] [Abstract][Full Text] [Related]
12. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
15. Immunotactoid glomerulopathy leading to the discovery of POEMS syndrome
.
Philipponnet C; Kemeny JL; Garrouste C; Soubrier M; Heng AE
Clin Nephrol; 2017 Jun; 87(6):310-315. PubMed ID: 28291506
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
17. A case of immunotactoid glomerulopathy in a patient with monoclonal gammopathy of renal significance.
Campdesuner V; Teklie Y; Lattanzio N; Lorenzo C; Bell S; Rodriguez Y; Sastry A
J Community Hosp Intern Med Perspect; 2021 Jan; 11(1):60-64. PubMed ID: 33552417
[TBL] [Abstract][Full Text] [Related]
18. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
20. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
